Related references
Note: Only part of the references are listed.OKADAIC ACID-INDUCED TAU PHOSPHORYLATION IN RAT BRAIN: ROLE OF NMDA RECEPTOR
P. K. Kamat et al.
NEUROSCIENCE (2013)
Functional significance of glycogen synthase kinase-3 regulation by serotonin
Abigail M. Polter et al.
CELLULAR SIGNALLING (2012)
Pretreatment with Memantine Prevents Alzheimer-Like Alterations Induced by Intrahippocampal Okadaic Acid Administration in Rats
Eduardo Rigon Zimmer et al.
Current Alzheimer Research (2012)
Greater cognitive deterioration in women than men with Alzheimer's disease: A meta analysis
Karen Irvine et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2012)
Gender differences in apolipoprotein D expression during aging and in Alzheimer disease
Cristina Ordonez et al.
NEUROBIOLOGY OF AGING (2012)
Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents
Brian C. Shonesy et al.
NEUROBIOLOGY OF AGING (2012)
Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia
Simone Guadagna et al.
NEUROBIOLOGY OF AGING (2012)
α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation
Yan Wang et al.
NEUROPHARMACOLOGY (2012)
LITHIUM ATTENUATES BUPIVACAINE-INDUCED NEUROTOXICITY IN VITRO THROUGH PHOSPHATIDYLINOSITOL-3-KINASE/THREONINE-SERINE PROTEIN KINASE B- AND EXTRACELLULAR SIGNAL-REGULATED KINASE-DEPENDENT MECHANISMS
Z. Wang et al.
NEUROSCIENCE (2012)
Xanthoceraside attenuates amyloid β peptide25-35-induced learning and memory impairments in mice
Ping Lu et al.
PSYCHOPHARMACOLOGY (2012)
Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model
Rahul Agrawal et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation
Ruiping Zhao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission
Ann Van der Jeugd et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Ludovic Martin et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β
Ludovic Martin et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease
R. Scott Bitner et al.
NEUROPHARMACOLOGY (2011)
THE N-TERMINAL 5-MER PEPTIDE ANALOGUE P165 OF AMYLOID PRECURSOR PROTEIN EXERTS PROTECTIVE EFFECTS ON SH-SY5Y CELLS AND RAT HIPPOCAMPUS NEURONAL SYNAPSES
P. Wang et al.
NEUROSCIENCE (2011)
EFFECT OF GLYCOGEN SYNTHASE KINASE 3 β-MEDIATED PRESENILIN 1 PHOSPHORYLATION ON AMYLOID β PRODUCTION IS NEGATIVELY REGULATED BY INSULIN RECEPTOR CLEAVAGE
M. Maesako et al.
NEUROSCIENCE (2011)
NUCLEAR PROTEIN PHOSPHATASE-1: AN EPIGENETIC REGULATOR OF FEAR MEMORY AND AMYGDALA LONG-TERM POTENTIATION
K. Koshibu et al.
NEUROSCIENCE (2011)
Inhibiting NF-κB activation and ROS production are involved in the mechanism of silibinin's protection against D-galactose-induced senescence
Qiong Wang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats
Trine Damgaard et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors
Kurt R. Brunden et al.
EXPERIMENTAL NEUROLOGY (2010)
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model
Niall M. Corcoran et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain
Ting Zhang et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells
Ke-Wu Zeng et al.
NEUROPHARMACOLOGY (2010)
Tau protein and tau aggregation inhibitors
Bruno Bulic et al.
NEUROPHARMACOLOGY (2010)
Spatial Learning and Expression Patterns of PP1 mRNA in Mouse Hippocampus
S. Haege et al.
NEUROPSYCHOBIOLOGY (2010)
Pregnenolone sulfate infused in lateral septum of male rats impairs novel object recognition memory
Federico Nanfaro et al.
PHARMACOLOGICAL REPORTS (2010)
Mechanisms of tau-induced neurodegeneration
Khalid Iqbal et al.
ACTA NEUROPATHOLOGICA (2009)
Dysregulation of Insulin Signaling, Glucose Transporters, O-GlcNAcylation, and Phosphorylation of Tau and Neurofilaments in the Brain Implication for Alzheimer's Disease
Yanqiu Deng et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice
Yumiko Uno et al.
BRAIN RESEARCH (2009)
Protective effects of xanthoceraside on learning and memory impairment induced by A beta(25-35) in mice
Tian-Yan Chi et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2009)
Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-β-induced neuronal cell death
Min-Young Noh et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation
Chih-Li Lin et al.
NEUROBIOLOGY OF AGING (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia
Rahul Agrawal et al.
NEUROPHARMACOLOGY (2009)
Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain
Masatake Fujimura et al.
NEUROTOXICOLOGY (2009)
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Biochemistry of Tau in Alzheimer's disease and related neurological disorders
Nicolas Sergeant et al.
EXPERT REVIEW OF PROTEOMICS (2008)
Phosphatidylinositol-3-kinase activation blocks amyloid beta-induced neurotoxicity
Kyu-Yong Lee et al.
TOXICOLOGY (2008)
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms
Emmanuel Planel et al.
JOURNAL OF NEUROSCIENCE (2007)
Kainate induces AKT, ERK and cdk5/GSK3 beta pathway deregulation, phosphorylates tau protein in mouse hippocampus
N. Crespo-Biel et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Tau phosphorylation and aggregation in Alzheimer's disease pathology
J Avila
FEBS LETTERS (2006)
Glycogen synthase kinase 3β phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism
T Li et al.
BIOCHEMISTRY (2006)
Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway
M Salkovic-Petrisic et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture
X Li et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation
F Liu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Akt activity in Alzheimer's disease and other neurodegenerative disorders
A Rickle et al.
NEUROREPORT (2004)
PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations
L Baki et al.
EMBO JOURNAL (2004)
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
TD Gould et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Tau phosphorylation in neuronal cell function and dysfunction
GVW Johnson et al.
JOURNAL OF CELL SCIENCE (2004)
Glycogen synthase kinase-3β-mediated tau phosphorylation in cultured cell lines
CWC Lee et al.
NEUROREPORT (2003)
Hormone replacement therapy and incidence of Alzheimer disease in older women - The Cache County Study
PP Zandi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Delayed induction of αB-crystallin in activated glia cells of hippocampus in kainic acid-treated mouse brain
Y Che et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
DAE Cross et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment
M Sharma et al.
LIFE SCIENCES (2001)
Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice
JJ Lucas et al.
EMBO JOURNAL (2001)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Share Paper
